Economics of vaccination

Vaccines are a highly effective technology to counter important health issues. In recent years, vaccines have been developed for pathogens causing pneumonia and diarrhoea, two of the leading causes of childhood deaths in the world.

Research by members of CHE has investigated the economic burden of vaccine-preventable illnesses as well as the cost-effectiveness of specific new vaccines and implementation strategies, primarily in low- and middle-income countries (LMICs).

Ongoing and developmental CHE research builds on this base; exploring issues such as:

  • broader non-health benefits of vaccine investment (e.g. education or cognitive development)
  • targeting of vaccination to key, vulnerable populations
  • incorporation of health-equity trade-offs into economic evaluation approaches

Research staff involved: Andrew Mirelman (Global Health team), Richard Cookson (TEEHTA team).